News
At 42, Moumita Ghosh proved that weight loss isn’t just for the young. Without crash diets or fancy programs, this school ...
Long-term use of tirzepatide shows sustained and significant weight loss in adults with overweight or obesity.
Many individuals, like Bangalore's Sristi, find that simply increasing protein intake doesn't guarantee weight loss. While protein is essential, exper ...
News-Medical.Net on MSN2d
Traditional BMI cut-offs overestimate overweight and obesity in male athletesNew research to be presented at this year's European Congress on Obesity (ECO 2025, Malaga, Spain, 11-14 May) shows that the internationally recognized body mass index (BMI) cut-off points greatly ...
News Medical on MSN9d
3-year study of tirzepatide shows that most patients only gain 5% or less from their lowest or ‘nadir’ weightNote – this is an early press release from the European Congress on Obesity in Malaga, Spain, 11-14 May. Please credit the congress when using this research.* New research to be presented at this year ...
Medical Xpress on MSN6d
Tirzepatide can produce clinically meaningful weight loss for at least 3 years in adults with overweight or obesity who don’t have diabetesLongest international trial on the effects of tirzepatide on weight in 700 adults with overweight or obesity and prediabetes reveals three distinct patterns of weight loss trajectories, with patients ...
Pharmaceutical company Eli Lilly’s study of its tablet, orforglipron, has raised hopes of an effective and easy-to-use ...
For patients with posterior circulation stroke, alteplase administered at 4.5 to 24 hours after onset increases frequency of functional independence.
Kawasaki has introduced the new 2025 iteration of the Ninja 650 sports bike. Priced at Rs 7.27 lakh (ex-showroom), the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback